Search results
AbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal
Zacks via Yahoo Finance· 4 hours agoData from a mid-stage study shows that treatment with AbbVie's (ABBV) Elahere achieves an objective...
Cancer patients often do better with less intensive treatment, new research finds
Hartford Courant· 4 days agoScaling back treatment for three kinds of cancer can make life easier for patients without...
Repare (RPTX) Up 14% as Ovarian Cancer Combo Gets Fast Track Tag
Zacks via Yahoo Finance· 1 day agoRepare (RPTX) rises 14% as the FDA grants Fast Track designation to its investigational...
AbbVie's ovarian cancer therapy succeeds in mid-stage trial
Reuters· 1 day ago, opens new tab said on Thursday its therapy to treat patients with a type of ovarian cancer has met...
Pharma Stock Roundup: LLY's CFO Departs, ABBV, AZN Drugs Get CHMP Approval
Zacks via Yahoo Finance· 4 hours ago(mirvetuximab soravtansine) for heavily pre-treated patients with folate receptor-alpha (FRĪ±)...
Geron wins long-sought drug approval; Califf talks China, GLP-1s at BIO
BioPharma Dive via Yahoo Finance· 7 hours agoAfter 34 years, Geron finally has an approved medicine in Rytelo. Elsewhere, Shionogi disclosed...
Elahere and dosage: Strength, form, when it's given, and more
Medical News Today· 2 days agoElahere (mirvetuximab soravtansine-gynx) is a brand-name drug prescribed for certain types of ...
AbbVie makes oncology progress with two drug trials
Crain s Chicago Business· 1 day agoMultiple myeloma, the second-most common blood cancer, is characterized by abnormal proliferation of plasma cells, which can cause end-organ damage, AbbVie said in a statement ...
23andMe reports positive phase 2 data for cancer drug By Investing.com
Investing.com· 4 days agoThe drug, an anti-CD200R1 antibody, is being tested as a monotherapy for neuroendocrine and ovarian ...
Scaling back cancer treatment can help some patients without compromising outcomes, studies find
Euronews via Yahoo News· 4 days agoAvoiding surgery for ovarian cancer patients French researchers, for instance, found that patients...